| Income Statement |
| Total Revenue | 3.92M |
|
| Revenues (USD) | 3.92M |
| Cost of Revenue | 1.40M |
| Gross Profit | 2.52M |
| Operating Expenses | 2.95M |
| Research and Development Expense | 873.00K |
| Selling, General and Administrative Expense | 1.82M |
| Operating Income | -426.00K |
| Interest Expense | 6.00K |
| Income Tax Expense | 5.00K |
| Net Income | -432.00K |
| Net Income Common Stock | -432.00K |
| Net Income Common Stock (USD) | -432.00K |
| Consolidated Income | -432.00K |
| Earnings per Basic Share | -0.04 |
| Earnings per Basic Share (USD) | -0.04 |
| Earnings per Diluted Share | -0.04 |
| Earning Before Interest & Taxes (EBIT) | -421.00K |
| Earning Before Interest & Taxes (USD) | -421.00K |
| Weighted Average Shares | 12.08M |
| Weighted Average Shares Diluted | 12.08M |
| Balance Sheet |
| Cash and Equivalents | 1.37M |
| Cash and Equivalents (USD) | 1.37M |
| Trade and Non-Trade Receivables | 1.40M |
| Current Assets | 3.47M |
| Property, Plant & Equipment Net | 511.00K |
| Total Assets | 15.32M |
| Debt Current | 210.00K |
| Total Debt | 665.00K |
| Current Liabilities | 5.21M |
| Debt Non-Current | 455.00K |
| Total Liabilities | 6.09M |
| Accumulated Retained Earnings (Deficit) | -94.57M |
| Accumulated Other Comprehensive Income | -325.00K |
| Shareholders Equity | 9.24M |
| Shareholders Equity (USD) | 9.24M |
| Assets Non-Current | 11.85M |
| Total Debt (USD) | 665.00K |
| Deferred Revenue | 2.83M |
| Goodwill and Intangible Assets | 11.28M |
| Liabilities Non-Current | 878.00K |
| Trade and Non-Trade Payables | 1.24M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 193.00K |
| Net Cash Flow from Financing | -31.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -108.00K |
| Capital Expenditure | -27.00K |
| Issuance (Repayment) of Debt Securities | -21.00K |
| Net Cash Flow from Investing | -27.00K |
| Net Cash Flow from Operations | -40.00K |
| Effect of Exchange Rate Changes on Cash | -10.00K |
| Share Based Compensation | 131.00K |